Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Pablo E. Vivas-Meji"'
Autor:
José Roberto Estupiñan‐Jiménez, Valeria Villarreal‐García, Vianey Gonzalez‐Villasana, Pablo E. Vivas‐Mejia, Jose Manuel Vazquez‐Guillen, Patricio Adrián Zapata‐Morin, Marienid Flores‐Colón, Claudia Altamirano‐Torres, Ezequiel Viveros‐Valdez, Cristina Ivan, Mohammed H. Rashed, Recep Bayraktar, Cristina Rodríguez‐Padilla, Gabriel Lopez‐Berestein, Diana Resendez‐Perez
Publikováno v:
Thoracic Cancer, Vol 15, Iss 32, Pp 2298-2308 (2024)
Abstract Background Despite advances in screening and therapy, breast cancer (BC) remains the predominant cancer in women globally. Dysregulation of microRNAs (miRNAs) is pivotal in carcinogenesis across various cancers, including BC. Evidence indica
Externí odkaz:
https://doaj.org/article/a1b3346bdbed4eaaa2d23f4f940cb712
Autor:
Luis E. Velázquez-Vega, Michael Rivera-Robles, Annelis O. Sánchez-Álvarez, Pablo E. Vivas-Mejía, Miciely Aponte-Reyes, Ailed M. Cruz-Collazo, Nilmary Grafals-Ruiz, Stephanie Dorta-Estremera, Eliud Hernández-O'Farrill, Cornelis P Vlaar, Suranganie Dharmawardhane
Publikováno v:
Translational Oncology, Vol 44, Iss , Pp 101928- (2024)
Trastuzumab and trastuzumab-based treatments are the standard of care for breast cancer patients who overexpress the human epidermal growth factor receptor 2 (HER2). However, patients often develop resistance to trastuzumab via signaling from alterna
Externí odkaz:
https://doaj.org/article/08593e49e06c4c999cc8684c83fb0cd2
Autor:
Betzaida Castillo Cruz, Sandra Chinapen Barletta, Bryan G. Ortiz Muñoz, Adriana S. Benitez-Reyes, Omar A. Amalbert Perez, Alexander C. Cardona Amador, Pablo E. Vivas-Mejia, Gabriel L. Barletta
Publikováno v:
Pharmaceuticals, Vol 17, Iss 10, p 1344 (2024)
Background: Encapsulation of siRNA fragments inside liposome vesicles has emerged as an effective method for delivering siRNAs in vitro and in vivo. However, the liposome’s fluid-phospholipid bilayer of liposomes allows siRNA fragments to diffuse o
Externí odkaz:
https://doaj.org/article/d8e8f52e1e90405d9c6b309b2cd9736f
Autor:
Nilmary Grafals-Ruiz, Annelis O. Sánchez-Álvarez, Yasmarie Santana-Rivera, Eunice L. Lozada-Delgado, Robert J. Rabelo-Fernandez, Christian I. Rios-Vicil, Fatima Valiyeva, Pablo E. Vivas-Mejia
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionGlioblastoma (GBM) is a highly aggressive and lethal primary brain tumor. Despite limited treatment options, the overall survival of GBM patients has shown minimal improvement over the past two decades. Factors such as delayed cancer diag
Externí odkaz:
https://doaj.org/article/729159b29ebf449a8320808f42799637
Publikováno v:
Journal of Clinical and Translational Science, Vol 8, Pp 26-26 (2024)
OBJECTIVES/GOALS: This project focuses on investigating the potential of Simalikalactone D (SKD) as an anticancer agent, exploring the mechanisms underlying SKD’s induction of cell death, and assessing the impact of SKD on diverse breast cancer cel
Externí odkaz:
https://doaj.org/article/4f76c2223a14459c84c9f4538c391489
Autor:
Betzaida Castillo Cruz, Marienid Flores Colón, Robert J. Rabelo Fernandez, Pablo E. Vivas-Mejia, Gabriel L. Barletta
Publikováno v:
ACS Omega, Vol 7, Iss 4, Pp 3731-3737 (2022)
Externí odkaz:
https://doaj.org/article/57cdd35469424d47a23ed4ae224ef9dc
Autor:
Valeria Villarreal-García, José Roberto Estupiñan-Jiménez, Pablo E. Vivas-Mejía, Vianey Gonzalez-Villasana, José Manuel Vázquez-Guillén, Diana Reséndez-Pérez
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Breast cancer (BC) is the most common cancer in women worldwide. This highly heterogeneous disease is molecularly stratified into luminal A, luminal B, HER2, triple-negative/basal-like, and normal-like subtypes. An important aspect in BC progression
Externí odkaz:
https://doaj.org/article/4e62908643124976bd98834fb509f947
Publikováno v:
Frontiers in Medical Technology, Vol 3 (2021)
Glioblastoma (GBM) is the most malignant form of all primary brain tumors, and it is responsible for around 200,000 deaths each year worldwide. The standard therapy for GBM treatment includes surgical resection followed by temozolomide-based chemothe
Externí odkaz:
https://doaj.org/article/236f1978127849348c04f955b425cf57
Autor:
Jorge Billoch, Mónica Rivera-Díaz, Maria Marcos, Pablo E. Vivas-Meji, Mario Quintero, Ileabett Echevarria
Publikováno v:
Cancer Research. 72:5053-5053
Astrocytoma, the tumor of astrocytic glial cells, is the most common type of central nervous system (CNS) neoplasms, accounting for more than 60% of all primary brain tumors. As histology-based classification is highly subjective, there is a need for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97a394cc83266b9ce1aaa817df91f493
https://doi.org/10.1158/1538-7445.am2012-5053
https://doi.org/10.1158/1538-7445.am2012-5053
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Ovarian cancer is the deadliest of gynecological malignancies with approximately 49% of women surviving 5 years after initial diagnosis. The standard of care for ovarian cancer consists of cytoreductive surgery followed by platinum-based combination
Externí odkaz:
https://doaj.org/article/bca2298851b7483593992797ac07ddb7